Connect with us
Anglostratits

Business

A Model for Africa: Côte d’Ivoire Health Ministry Announces New Initiative to Become Self-Sufficient in Paediatric Cardiology Surgery

Published

3 years ago

on

Health Ministry

The goal of the new initiative is to build a national effort to diagnose and treat many more children

ABIDJAN, Ivory Coast, July 7, 2023/APO Group/ — 

Launched by Mitrelli Group, Menomadin Foundation, Save a Child’s Heart, Côte d’Ivoire Health Ministry and Abidjan Institute of Cardiology; Côte d’Ivoire Minister of Health: “Health-independence is a national strategic priority, and this project is a major step on the road to that vital goal.” ; Taking part in the project: Mitrelli’ s health subsidiary Promed International (Switzerland) and the Sylvan Adams Children’s Hospital (Israel), AFCAO and CHU Nantes (France).

The Mitrelli Group (https://Mitrelli.com/), the Menomadin Foundation (https://MenomadinFoundation.com/), Save a Child’s Heart (https://SaveaChildsHeart.org/), and the Côte d’Ivoire Health Ministry, this week announced an innovative local-capacity-building initiative in Côte d’Ivoire to establish the country’s local capabilities in the field of life-saving paediatric cardiac surgery, and enable the country to become a model for self-sufficiency in this field in the continent.

The initiative is rooted in the “UN’s Sustainable Development Goal to promote Good Health and Well Being”.

Approximately 1 in every 100 babies born in the world suffers from congenital heart disease (CHD), which are structural heart anomalies that occur during pregnancy when the heart or major blood vessels fail to develop properly. CHD is the most common type of birth defect, but with advanced medical care and treatment, the chances of infants and children fully recovering from CHD and living normal adult lives are better than ever. However, in countries where the necessary treatments are unavailable, CHD is the leading cause of mortality in the first year of life.

According to the WHO (https://apo-opa.info/3O1Ps2F), 2,700 out of 300,000 births registered each year in Côte d’Ivoire, suffer from congenital heart disease. However, the screening rate for these congenital heart diseases is very low (11%).

The goal of the new initiative is to build a national effort to diagnose and treat many more children, while jointly establishing Côte d’Ivoire’s paediatric cardiac surgery health-independence with advanced medical knowledge and resources.

As part of this new partnership, projected to last for 5 years, the Institut de Cardiologie d’Abidjan’s medical staff will undergo advanced training in various heart-related procedures from French and Israeli cardiology teams, enhancing their existing professional capabilities. Delegations of surgeons will travel throughout the year to Côte d’Ivoire, to perform operations on young patients, and provide training for local medical teams. In addition, medical teams from Côte d’Ivoire will benefit from state-of-the-art training in Israel in different fields of paediatric cardiac care.

The project will serve Côte d’Ivoire as a model and a reference point for paediatric cardiac surgery in Africa

The project will serve Côte d’Ivoire as a model and a reference point for paediatric cardiac surgery in Africa – not only reducing mortality rates but also improving quality of life for children. Meanwhile, the most serious and urgent cases will be transferred for immediate care in Israel.

The announcement of the initiative was made at a special meeting at the Côte d’Ivoire Ministry of Health and included the participation of nine children with heart deficiencies, ranging between the ages of 1 to 13 years old, who are traveling to Israel in the coming days to undergo life-saving heart procedures at the Sylvan Adams Children’s Hospital through Save a Child’s Heart.

In 2020, during the early stages of the project, the foundation, “Children of Africa” under the patronage of First Lady Mrs. Dominique Ouattara, Mitrelli Group, Menomadin Foundation and the NGO “Save a Child’s Heart”, worked together to facilitate successful surgeries in Israel for five children suffering from cardiologic conditions.

Minister of Health of Cote d’Ivoire Mr. Pierre Dimba spoke on the importance of health independence as a strategy of the government. “Patients with heart defects require not only surgery but also post-treatment. Sending children abroad for surgery is a blessing but not a long-term solution. Achieving health-independence in the field of paediatric cardiological care especially, is a national strategic priority, and this project is the first step on the road to that vital goal. Our vision is to stop outsourcing our healthcare, and instead begin to export our own capabilities to help others.”

He added, “We are extremely pleased with the cooperation with our partners and the treatments of our children at the Sylvan Adams Children’s Hospital through Save a Child’s Heart and we are looking forward to establishing this extremely important and strategic health model for our country and happy to see it serve as a model cross-Africa.”

Haim Taib, Founder and President of Mitrelli Group and Menomadin Foundation and President of Save a Child’s Heart Africa said: “This is an incredible opportunity to make a difference in the wellbeing of children and their future through upgrading local capacities and creating sustainable solutions. If 1% of children in the country need heart surgery, philanthropic activity, however blessed, is just a drop in the ocean. In order to create a significant, sustainable and long-term impact, the government must be involved, because only the government has the power to create a long-term solution. This is the Mitrelli model – to build long term sustainable development solutions in cooperation with our local partners in health, agriculture, education, and more, ​to create real impact. Together with Menomadin’s ability to provide solutions based on national roadmaps and impact management, I am sure that Cote d’Ivoire will be a model for additional countries.  We are extremely encouraged by Cote d’Ivoire leadership – the president and health minister – and their commitment to building a self-sufficient model to treat children, and proud to be working with such special partners.”

Eva Peled, Mitrelli’s Partner in Côte d’Ivoire stated: “We have been working with the government of Côte d’Ivoire and its ministry of health for several years. We discovered a wonderful country with many hidden gems, among which is the Abidjan Institute of Cardiology (ICA). The ambitious vision of His Excellency Alassane Ouattara, President of Côte d’Ivoire, has made the health sector a priority for the nation’s citizens. Under the leadership of Prime Minister Patrick Achi and the guidance of the Minister of Health Pierre Dimba, we are honored and proud to join forces in this humane initiative, which reflects our shared beliefs and values. We believe that Côte d’Ivoire will not only become a point of reference for cardiac surgeries, but for many other sectors in Africa.”

Professor Mohamed Ly, cardiac surgeon, and President of the AFCOA, added: “This extraordinary partnership signifies a monumental step towards providing essential surgical care and empowering local teams, ensuring a brighter future for children who currently lack access to these critical services.”

Simon Fisher, Executive Director of Save a Child’s Heart: “We are very grateful to the Mitrelli Group and the Menomadin Foundation for their partnership and for initiating the expansion to Cote d’Ivoire of Save a Child’s Heart activities.

The arrival of the group of nine children in Israel for lifesaving treatment at the Sylvan Adams Children’s Hospital is a major step in the implementation of this strategic initiative in partnership with the Côte d’Ivoire Health Ministry and the Institut de Cardiologie d’Abidjan. This group of children, and future groups to be treated in Israel, will complement the capacity building efforts in Côte d’Ivoire  led by the Association Française du Coeur pour l’Afrique de l’Ouest (AFCAO) and the Centre Hospitalier Universitaire (CHU) de Nantes from France turning this initiative into an truly international project that will lead to Côte d’Ivoire to  becoming self-sustainable in Paediatric Cardiac Care and a Regional leader in the field.”

Distributed by APO Group on behalf of Mitrelli Group.

Related Topics:
Continue Reading
Advertisement

Business

Africa’s Lithium Pipeline Gains Momentum as Global Supply Deficits Loom

Published

8 hours ago

on

April 9, 2026

By

Energy Capital

The upcoming African Mining Week 2026 – taking place from October 14-16 in Cape Town – will connect global investors with prospects within the lithium industry amidst an anticipated resource supply deficit by 2028

CAPE TOWN, South Africa, April 9, 2026/APO Group/ –Rising demand for lithium is positioning Africa to attract foreign investment, accelerate local beneficiation and strengthen its role in securing the global battery supply chain. A recent forecast by Wood Mackenzie projects that global lithium demand could exceed 13 million tons by 2050 under an accelerated energy transition scenario. This surge is expected to place significant pressure on supply, with deficits emerging as early as 2028. Without substantial new investments, existing lithium projects will struggle to meet demand beyond the mid-2030s.

 

Against this backdrop, Africa’s growing pipeline of greenfield and development-stage lithium projects positions the continent as an increasingly important contributor to global supply security. In 2025, Africa ranked as the largest source of new lithium supply globally, with new output from the region exceeding that of the rest of the world combined. This milestone underscores the continent’s potential to scale production and strengthen its role in the global battery minerals market.

Emerging Lithium Producers Strengthen Africa’s Supply Pipeline

Even under a slower energy transition scenario, Wood Mackenzie projects that lithium markets will remain adequately supplied until 2037, before entering deficit. This outlook reinforces Africa’s strategic role as new projects across Mali, Zimbabwe, Ghana and Namibia advance toward production.

In the Democratic Republic of the Congo (DRC), Zijin Mining, AVZ Minerals and KoBold Metals are expected to begin operations at the Manono lithium project in mid-to-late 2026, marking the country’s first lithium output. Ranked among the world’s largest hard-rock lithium deposits, Manono is expected to begin exports shortly after commissioning, diversifying DRC’s mineral output while strengthening the continent`s contribution to the global electric vehicles and battery supply chain.

Mali Emerges as a Regional Lithium Hub

Mali is also rapidly positioning itself as a key lithium producer. The Bougouni Lithium Project, commissioned in 2025, currently produces approximately 125,000 tons per annum of concentrate, with Phase Two expansion plans underway that could nearly double production capacity.

Meanwhile, the Goulamina Lithium Project, one of the largest spodumene deposits globally, is producing around 506,000 tons of spodumene concentrate annually, with expansion plans targeting one million tons per year. Together, these projects are expected to significantly strengthen Mali and Africa’s position within the global lithium market.

Ghana and Zimbabwe Expand Lithium Production and Value Addition

In Ghana, the Ewoyaa Lithium Project, developed by Atlantic Lithium, is set to become the country’s first lithium-producing mine, with production targeted for late 2027. The project is expected to produce 3.58 million tons of spodumene concentrate grading 6% and 5.5%, alongside approximately 4.7 million tons of secondary product, further strengthening Africa’s contribution to global lithium supply.

Meanwhile, Zimbabwe – currently Africa’s largest lithium producer – is accelerating efforts to move up the value chain. Government policies restricting the export of raw lithium are encouraging investment in local processing and beneficiation facilities, supporting the production of higher-value lithium products and positioning the country as a key supplier to the global battery materials market.

Investment Momentum Builds Ahead of African Mining Week

With an estimated $276 billion in new investment required to avoid the forecast supply deficits beginning in 2028, Africa’s lithium-rich countries are well positioned to attract the capital needed to expand production and downstream processing.

In this context, African Mining Week 2026 – scheduled for October 14–16 in Cape Town – will serve as a key platform for global investors, project developers and policymakers to engage on opportunities within Africa’s lithium sector. As the continent’s premier mining investment event, the conference will feature high-level discussions, project showcases and strategic networking sessions aimed at accelerating partnerships across the lithium value chain.

Distributed by APO Group on behalf of Energy Capital & Power.

Continue Reading

Business

Afreximbank delivers strong FY2025 results; with a total assets and contingencies base of US$48.5 billion

Published

8 hours ago

on

April 9, 2026

By

Afreximbank

Total assets and contingencies rose by 21% to US$48.5 billion, up from US$40.1 billion as at 31 December 2024, underscoring the Bank’s consistent growth trajectory

The Group’s balance sheet is at its strongest level ever, with liquidity levels and capitalisation well above target and good asset quality

CAIRO, Egypt, April 9, 2026/APO Group/ –African Export-Import Bank (“Afreximbank” or the “Bank”) (www.Afreximbank.com) and its subsidiaries (the “Group”) has announced strong results for the year ended 31 December 2025, underscoring sustained financial resilience, increased market confidence and strategic execution.

 

Total assets and contingencies rose by 21% to US$48.5 billion, up from US$40.1 billion as at 31 December 2024, underscoring the Bank’s consistent growth trajectory.

Net loans and advances for the Group closed the year at US$33.5 billion (FY’2024: US$29.0 billion), an increase of 16%, supported by continued disbursements across the continent and the Caribbean through various product offerings. The Group funded strategic priorities areas such as manufacturing, infrastructure, food security and climate adaptation.

The Group’s non-performing loan (NPL) ratio remained stable at 2.43% (FY’2024: 2.33%), demonstrating consistent portfolio quality.

The Group’s liquidity position remained robust, with cash and cash equivalents at US$6.0 billion (FY’2024: US$4.6 billion). Liquid assets accounted for 14% of total assets, above the Bank’s strategic minimum level of 10%. Shareholders’ funds grew by 17% to US$8.4 billion as at 31 December 2025, driven by net income of US$1.2 billion, and new equity inflows of US$299.4 million raised under the General Capital Increase II.

Gross Income increased by 6.06% reaching US$3.5 billion in FY’2025 from US$3.3 billion achieved in FY’2024.

Operating expenses increased to US$459.2 million (FY’2024: US$367.7 million), reflecting strategic staff expansion, and inflationary pressures with the Group maintained strong cost efficiency resulting in a cost-to-income ratio of 21% (FY’2024: 18%) well below the strategic ceiling of 30%.

Contrary to concerns raised by some rating agencies during the year, the Bank accessed international bond markets by successfully raising over US$800 million from Japan and China, courtesy of the Samurai and Panda bonds in 2025. This demonstrated the Group’s fund-raising capabilities and the solid nature of the Bank’s DNA as a pan-African multilateral financial institution committed to ensuring that Africa’s full and sustainable self-reliance remain firm.

Net income increased by 19% to US$1.2 billion in 2025, up from US$973.5 million in the prior year. These results were achieved through the expanded delivery of tailored financial and advisory solutions that supported trade, fostered industrialisation and enhanced economic self-reliance.

Highlights of the results for Afreximbank Group are shown below:

Financial Performance Metrics

FY’2025

FY’2024
Gross Income (US$ billion)

3.5

3.3
Net Income (US$ million)

1,156.8

973.5
Return on average equity (ROAE)

15%

15%
Return on average assets (ROAA)

3.04%

2.96%
Cost-to-income ratio

21%

18%

 

Financial Position Metrics

FY’2025

9M’2024
Total Assets (US$ billion)

42.3

35.3
Total Liabilities (US$ billion)

33.9

28.1
Shareholders’ Funds (US$ billion)

8.4

7.2
Non-performing loans ratio (NPL)

  2.43%

2.33%
Cash/Total assets

14%

13%
Capital Adequacy ratio (Basel II)                                                                         23%

24%

 

Mr. Denys Denya, Afreximbank’s Senior Executive Vice President, commented:

 

“Despite continuing global geopolitical challenges and disruptions caused by some rating actions, the Group delivered excellent financial performance in 2025, a fitting tribute to a decade of consequential leadership under Professor Oramah, with total assets and contingencies reaching $49 billion. Pleasingly, the Group is way ahead on most of it targets in delivery on its 6th Strategic plan that ends on 31 December 2026. With recently established subsidiaries such as FEDA and AfrexInsure becoming profitable, Net income grew by 19% to stand at US$1.2 billion, underpinned by a strong capital base of US$8.4 billion. The Group’s balance sheet is at its strongest level ever, with liquidity levels and capitalisation well above target and good asset quality. These results are a testament to the unwavering execution by the Group’s hard working human capital. We entered 2026 financial year with significant momentum, ready to scale the Group’s impact, accelerate trade integration and value addition across Global Africa, and deliver greater value to our shareholders.”

Distributed by APO Group on behalf of Afreximbank.

Continue Reading

Events

Chinese Mainland’s Largest Conference on Chest Pain Centres Goes Global in Hong Kong

Published

11 hours ago

on

April 9, 2026

By

Hong Kong

With robust lineup of medical conventions in 2026

HONG KONG SAR – Media OutReach Newswire – 9 April 2026 – Marking yet another milestone as the World’s Meeting Place, Hong Kong became the first city outside Chinese Mainland to host the nation’s largest conference on chest pain centres – the 15th China Chest Pain Centers Congress (CCPCC 2026), thanks to the effort of Hong Kong Convention Ambassador (HKCA) appointed by the Hong Kong Tourism Board (HKTB).
Together with two other high-profile and hugely successful medical congresses – the 41st Asia Pacific Academy of Ophthalmology Congress in February and the 17th Asian Congress of Oral & Maxillofacial Surgery in March, Hong Kong’s medical science events space was off to a strong start in 2026.

Ms Marilyn Tham, General Manager of Mega Events, MICE & Cruise of the HKTB said, “Hong Kong’s leading edge in medical sciences coupled with the city’s world-class venues and destination appeal have enabled notable success for internationally significant medical events. CCPCC 2026 is one of the large-scale medical conventions confirmed for 2026. Such robust lineup reflects event organisers’ confidence in Hong Kong as a premier hub for advancing global exchanges on medical sciences.”

Over 10 medical conventions have secured a spot in Hong Kong this year, spanning diverse disciplines, from cytology to oncology, antimicrobial resistance and more (see full list below). The breadth and depth of the events reflects Hong Kong’s growing appeal as the premier convention hub where global medical minds meet.

Globalising Chest Pain Leadership from Hong Kong

Held on 3-4 April 2026 at the Hong Kong Convention and Exhibition Centre with a concurrent venue in Shenzhen, CCPCC 2026 converged 3,000 healthcare leaders, physicians, nurses, researchers, policymakers and industry experts from Hong Kong, Chinese Mainland, the Belt and Road countries and beyond. The rich topics explored across two days encompassed cutting-edge healthcare innovations, AI-assisted clinical decision-making, intelligent emergency response systems and international accreditation standards.

Co-organised by Hospital Authority (HA) of Hong Kong, the National Clinical Research Center for Interventional Medicine, the Guangdong Chest Pain Centers Association, the Chinese Cardiovascular Association (CCA) and Oriental Huaxia Cardiovascular Health Research Institute (OHCHRI), Suzhou Industrial Park, CCPCC 2026 showcased conducive partnership.

Mr. Wenming Zeng, Secretary-General of OHCHRI, remarked, “The global influence of CCPCC has been growing over the years. Thanks to Hong Kong’s strategic location, leading medical standing and its unique role bridging Chinese Mainland and the world, this year’s congress has drawn even wider global participation, giving the event greater international significance. Hong Kong has helped showcase our event to the world, taking cardiovascular emergency intervention to a new height globally.”

A Launchpad for Mainland-spearheaded International Standards

Capitalising on Hong Kong’s strengths as a super-connector for fostering globalisation, CCPCC 2026 released for the first time the “International Standards on Chest Pain Center Construction and Accreditation”, marking Mainland’s global leadership in cutting-edge cardiovascular emergency intervention. Leveraging Hong Kong’s internationalisation, the efforts to foster global policy support and implementation of the standards will contribute to fair, accessible and timely intervention for cardiovascular emergencies around the world.

Another Significant Win for HKCA Programme on its 5th Anniversary

As a HKTB-appointed HKCA, Prof Lu Shi-Juan, who is a Member of Hainan Medical Association Cardiovascular Professional Committee, played an instrumental role in bringing CCPCC 2026 to Hong Kong. This marked the latest success story of the HKCA programme, as HKTB celebrated the programme’s milestone 5th anniversary with a HKCA Networking Cocktail Event on 31 March, 2026.

Prof Lu noted, “As a Hong Kong International Convention Ambassador, I have worked closely with the HKTB to bring CCPCC to Hong Kong, which is a gateway to the global stage. Hosting the conference here showcases how Hong Kong can elevate Mainland conferences internationally, foster cross‑border knowledge exchange and help shape the future development of the broader medical and professional community.”
The HKCA programme bands together over 170 local and mainland sector leaders of 13 industries and academics to champion Hong Kong as the World’s Meeting Place. Their initiative and connections have helped Hong Kong secure 50 convention wins that have brought in nearly 100,000 high-value overnight MICE visitors.

Strong Medical Events Lineup in 2026

Over 10 medical conventions will be held in 2026 across various disciplines, including ophthalmology, oncology, antimicrobial resistance and cytology.

Event

(*first-ever in Hong Kong)

 Date / Venue Highlights
The 41st Asia-Pacific Academy of Ophthalmology Congress 2026 5-8 Feb,

HKCEC

 The largest and most authoritative ophthalmology congress in APAC, returning to HK for the fifth time, with record-breakingattendance of 11,000+ participants from 111 countries and regions.
The 17th Asian Congress on Oral and Maxillofacial Surgery 2026 27-29 Mar,

HKCEC

 Held in Hong Kong for the second time, bringing together internationally acclaimed speakers, globally renowned experts and young surgeons to foster academic exchange and professional development.
The 15th China Chest Pain Centers Congress 3-4 Apr,

HKCEC

 Chinese Mainland’s largest conference on chest pain centres, hosted for the first time outside Chinese Mainland.
*Asian Federation of Cytology Societies Conference 2026 8-10 May,

Postgraduate Education Centre, Prince of Wales Hospital

 First edition in Hong Kong, bringing together regional and international cytology experts for academic exchange and collaboration.
International Symposium on Antimicrobial Agents and Resistance 2026 12-14 Jun,

HKCEC

 A key international platform for academic exchange on infectious diseases and antimicrobial resistance.
European Society of Medical Oncology Targeted Anticancer Therapies Asia 2026 12-14 Jun,

Kerry Hotel

 A key Asia-Pacific platform for showcasing the latest advances in early-phase oncology drug development, targeted therapies and precision oncology.
Federation of Asian and Oceanian Biochemists and Molecular Biologists Conference 2026 10-13 Aug,

Cheung Kung Hai Conference Centre, The University of Hong Kong

 A major regional scientific meeting in biochemistry and molecular biology, bringing together researchers, educators and professionals from across Asia and Oceania for academic exchange and collaboration.
* 2026 World Cancer Congress 24-26 Sep,

HKCEC

 A leading global forum advancing cancer control and research.
2026 Asia-Pacific Longevity Medicine International Summit 1-4 Oct,

TBC

 A leading international platform and regional collaborative hub dedicated to longevity medicine and innovation, attracting top longevity scientists, medical experts, cross-industry entrepreneurs and investors from over 50 countries.
10th Asia Cornea Society Scientific Meeting 2026 11-13 Dec,

TBC

 A key regional forum for cornea specialists to exchange the latest clinical insights, diagnostics and treatments, and to strengthen collaboration across the Asia-Pacific ophthalmology community.
Association of Pacific Rim Universities (APRU) Global Health Conference 2026 7-9 Dec,

Henry Cheng International Conference Centre, CUHK

 Third time in Hong Kong, convening leading academics, policymakers and practitioners to address critical global health challenges through interdisciplinary collaboration and innovation.

 

Continue Reading

Trending